Cargando…
PDE3 inhibition with enoximone as first‐line therapy for severe persistent pulmonary hypertension of the newborn during neonatal transport: a case report
Severe Persistent pulmonary hypertension of the newborn (PPHN) can be effectively treated with a PDE3 inhibitor as first‐line treatment during neonatal transport when iNO is not readily available. Starting iNO as soon as possible is strongly advised because of the complementary actions of both thera...
Autores principales: | van der Lee, Robin, Peels, Barbara, Koopman‐Esseboom, Corine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5224780/ https://www.ncbi.nlm.nih.gov/pubmed/28096983 http://dx.doi.org/10.1002/ccr3.748 |
Ejemplares similares
-
(Oral) enoximone in asthma
por: Beute, Jan
Publicado: (2020) -
Enoximone in status asthmaticus
por: Schulz, Oscar, et al.
Publicado: (2020) -
Persistent pulmonary hypertension of the newborn
por: Sharma, Vinay, et al.
Publicado: (2015) -
Persistent Pulmonary Hypertension in the Newborn
por: Mathew, Bobby, et al.
Publicado: (2017) -
Combined verapamil and atenolol poisoning: resolution of cardiogenic shock with enoximone
por: Gallizzi, F, et al.
Publicado: (2001)